Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia.

Galluppi, Gerald R; Polhamus, Daniel G; Fisher, Jeannine M; Hopkins, Seth C; Koblan, Kenneth S

Galluppi, Gerald R; Polhamus, Daniel G; Fisher, Jeannine M; Hopkins, Seth C; Koblan, Kenneth S.

Affiliation

Galluppi GR; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts, USA.
Polhamus DG; Metrum Research Group, Tariffville, Connecticut, USA.
Fisher JM; Metrum Research Group, Tariffville, Connecticut, USA.
Hopkins SC; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts, USA.
Koblan KS; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts, USA.

CPT Pharmacometrics Syst Pharmacol ; 10(10): 1245-1254, 2021 10.

Article in En | MEDLINE | ID: mdl-34292664

Subject(s)

Pyrans; Receptors, G-Protein-Coupled; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Adolescent; Adult; Female; Humans; Male; Middle Aged; Young Adult; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Healthy Volunteers; Pyrans/pharmacokinetics; Pyrans/therapeutic use; Receptor, Serotonin, 5-HT1A; Receptors, G-Protein-Coupled/agonists; Schizophrenia/drug therapy; Serotonin 5-HT1 Receptor Agonists/pharmacokinetics; Serotonin 5-HT1 Receptor Agonists/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrans / Schizophrenia / Receptors, G-Protein-Coupled / Serotonin 5-HT1 Receptor Agonists Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: CPT Pharmacometrics Syst Pharmacol Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google